Patent considerations in the immunotherapy space: Claiming by function or target
Following on from our previous article, which explored antibody claiming by structure, the present article delves into some detail around the second type of format that is commonly used when claiming antibodies: claiming by function or target. As discussed in our previous article, claims that are directed solely towards protecting the functional aspect of the antibodies are typically too broad, in that the scope of the claim would extend to